Kathleen A Ashcraft

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Circulating Tumor

Dna Damage Response

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, Katherine Deland, Kathleen A Ashcraft, Amy E Stewart, Yaode Wang, Jianmin Fu, Kris C Wood, David G Kirsch, Michael B Kastan
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors. Molecular cancer therapeutics 23 (6) (2024)
Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, Katherine Deland, Kathleen A Ashcraft, Amy E Stewart, Yaode Wang, Jianmin Fu, Kris C Wood, David G Kirsch, Michael B Kastan
A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors. Molecular cancer therapeutics (2024)
Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, Katherine Deland, Kathleen A Ashcraft, Amy E Stewart, Yaode Wang, Jianmin Fu, Kris C Wood, David G Kirsch, Michael B Kastan
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors. Molecular cancer therapeutics 23 (6) (2024)